These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18089703)

  • 21. Pituitary and/or peripheral estrogen-receptor alpha regulates follicle-stimulating hormone secretion, whereas central estrogenic pathways direct growth hormone and prolactin secretion in postmenopausal women.
    Cosma M; Bailey J; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2008 Mar; 93(3):951-8. PubMed ID: 18089703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen-like potentiation of ghrelin-stimulated GH secretion by fulvestrant, a putatively selective ER antagonist, in postmenopausal women.
    Veldhuis JD; Yang RJ; Wigham JR; Erickson D; Miles JC; Bowers CY
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2557-64. PubMed ID: 25210881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
    Veldhuis JD; Evans WS; Bowers CY
    J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estradiol potentiates ghrelin-stimulated pulsatile growth hormone secretion in postmenopausal women.
    Veldhuis JD; Keenan DM; Iranmanesh A; Mielke K; Miles JM; Bowers CY
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3559-65. PubMed ID: 16804038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous Estrogen Regulates Somatostatin-Induced Rebound GH Secretion in Postmenopausal Women.
    Veldhuis JD; Erickson D; Yang R; Takahashi P; Bowers C
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4298-4304. PubMed ID: 27459535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2649-59. PubMed ID: 10946861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Model-projected mechanistic bases for sex differences in growth hormone regulation in humans.
    Farhy LS; Bowers CY; Veldhuis JD
    Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1577-93. PubMed ID: 17185408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kisspeptin immunoreactive cells of the ovine preoptic area and arcuate nucleus co-express estrogen receptor alpha.
    Franceschini I; Lomet D; Cateau M; Delsol G; Tillet Y; Caraty A
    Neurosci Lett; 2006 Jul; 401(3):225-30. PubMed ID: 16621281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature.
    Pantel J; Legendre M; Cabrol S; Hilal L; Hajaji Y; Morisset S; Nivot S; Vie-Luton MP; Grouselle D; de Kerdanet M; Kadiri A; Epelbaum J; Le Bouc Y; Amselem S
    J Clin Invest; 2006 Mar; 116(3):760-8. PubMed ID: 16511605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha-androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus.
    Lund TD; Hinds LR; Handa RJ
    J Neurosci; 2006 Feb; 26(5):1448-56. PubMed ID: 16452668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition.
    Veldhuis JD; Roemmich JN; Richmond EJ; Bowers CY
    Endocr Rev; 2006 Apr; 27(2):101-40. PubMed ID: 16434512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiestrogens upregulate estrogen receptor beta expression and inhibit adrenocortical H295R cell proliferation.
    Montanaro D; Maggiolini M; Recchia AG; Sirianni R; Aquila S; Barzon L; Fallo F; Andò S; Pezzi V
    J Mol Endocrinol; 2005 Oct; 35(2):245-56. PubMed ID: 16216906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release.
    Kansra S; Yamagata S; Sneade L; Foster L; Ben-Jonathan N
    Mol Cell Endocrinol; 2005 Jul; 239(1-2):27-36. PubMed ID: 15950373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The estrogen receptor (ER) alpha, but not ER beta, gene is expressed in hypothalamic growth hormone-releasing hormone neurons of the adult female rat.
    Shimizu T; Kamegai J; Tamura H; Ishii S; Sugihara H; Oikawa S
    Neurosci Res; 2005 May; 52(1):121-5. PubMed ID: 15811559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deterministic construct of amplifying actions of ghrelin on pulsatile growth hormone secretion.
    Farhy LS; Veldhuis JD
    Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1649-63. PubMed ID: 15718392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bipotential effects of estrogen on growth hormone synthesis and storage in vitro.
    Childs GV; Iruthayanathan M; Akhter N; Unabia G; Whitehead-Johnson B
    Endocrinology; 2005 Apr; 146(4):1780-8. PubMed ID: 15618363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp.
    Erickson D; Keenan DM; Farhy L; Mielke K; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1741-51. PubMed ID: 15613434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual secretagogue drive of burst-like growth hormone secretion in postmenopausal compared with premenopausal women studied under an experimental estradiol clamp.
    Erickson D; Keenan DM; Mielke K; Bradford K; Bowers CY; Miles JM; Veldhuis JD
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4746-54. PubMed ID: 15356089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological role of pituitary estrogen receptors ERalpha and ERbeta on progesterone receptor expression and action and on gonadotropin and prolactin secretion in the rat.
    Sánchez-Criado JE; Martín De Las Mulas J; Bellido C; Tena-Sempere M; Aguilar R; Blanco A
    Neuroendocrinology; 2004; 79(5):247-58. PubMed ID: 15205556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fulvestrant: a review of its use in hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
    McKeage K; Curran MP; Plosker GL
    Drugs; 2004; 64(6):633-48. PubMed ID: 15018596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.